ABSTRACT
Susceptibility to schizophrenia is mediated by genetic and environmental risk factors. Infection driven maternal immune activation (MIA) during pregnancy is a key environmental risk factor. However, little is known about how MIA during pregnancy could contribute to adult-onset schizophrenia. In this study, we investigated if maternal immune activation induces changes in methylation of genes linked to schizophrenia. We found that differentially expressed genes in schizophrenia brain were significantly enriched among MIA induced differentially methylated genes in the foetal brain in a cell-type-specific manner. Upregulated genes in layer V pyramidal neurons were enriched among hypomethylated genes at gestational day 9 (fold change = 1.57, FDR = 0.049) and gestational day 17 (fold change = 1.97, FDR = 0.0006). We also found that downregulated genes in GABAergic Rosehip interneurons were enriched among hypermethylated genes at gestational day 17 (fold change = 1.62, FDR= 0.03). Collectively, our results highlight a connection between MIA driven methylation changes during gestation and schizophrenia gene expression signatures in the adult brain. These findings carry important implications for early preventative strategies in schizophrenia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by National Institute for Health Research U.K. and John Fell Fund from the University of Oxford.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involves publicly available and anonymised human data, which can be obtained from the studies specified and referenced in our manuscript. GWAS data: https://www.medrxiv.org/content/early/2020/09/13/2020.09.12.20192922.external-links RNA-sequencing data: https://www.medrxiv.org/content/early/2020/11/09/2020.11.06.20225342.external-links Gene methylation data: https://www.sciencedirect.com/science/article/pii/S0006322316326713#s0090 Statements regarding the ethical approval of the collection of original data can be found in the studies, specified and referenced in our manuscript, that were responsible for the collection of said original data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Only publicly available, anonymised summary data was used during this study, and we can provide processed data upon reasonable request to the corresponding author. This study was subject to Oxford Universitys Research Integrity and Ethics Policy.
https://www.medrxiv.org/content/early/2020/09/13/2020.09.12.20192922.external-links
https://www.medrxiv.org/content/early/2020/11/09/2020.11.06.20225342.external-links
https://www.sciencedirect.com/science/article/pii/S0006322316326713#s0090